Primary prophylaxis of febrile neutropenia using long-acting granulocyte colony-stimulating factors in female patients receiving dose-dense biweekly chemotherapy in the clinical routine.

被引：0
|
作者：
Kurbacher, Christian M. [1 ]
Kurbacher, A. Tabea [1 ]
Monreal, Katja [1 ]
Schweitzer, Claudia [1 ]
Sperling, Sandra [1 ]
Kolberg, Gabriele [1 ]
Kurbacher, Jutta A. [1 ]
机构：
[1] Gynecol Ctr Bonn Friedenspl, Bonn, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e20693
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Primary prophylaxis of febrile neutropenia in female patients receiving dose-dense biweekly chemotherapy in the clinical routine using long-acting granulocyte colony-stimulating factors is safe and effective
    Kurbacher, C. M.
    Kurbacher, A. T.
    Monreal, K.
    Herz, S.
    Sperling, S.
    Kurbacher, J. A.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 152 - 152
  • [2] Primary prophylaxis of febrile neutropenia using long-acting granulocyte colony-stimulating factors in female patients receiving dose-dense biweekly chemotherapy: A single-institution experience
    Kurbacher, C. M.
    Kurbacher, A. T.
    Monreal, K.
    Herz, S.
    Sperling, S.
    Kurbacher, J. A.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S245 - S246
  • [3] Febrile neutropenia prophylaxis with short- and long-acting granulocyte colony-stimulating factors during treatment of solid tumours
    Kwinta, Lukasz
    ONCOLOGY IN CLINICAL PRACTICE, 2020, 16 (01): : 9 - 13
  • [4] Efficacy, effectiveness and safety of long-acting granulocyte colony-stimulating factors for prophylaxis of chemotherapy-induced neutropenia in patients with cancer: a systematic review
    Alena M. Pfeil
    Kim Allcott
    Ruth Pettengell
    Gunter von Minckwitz
    Matthias Schwenkglenks
    Zsolt Szabo
    Supportive Care in Cancer, 2015, 23 : 525 - 545
  • [5] Efficacy, effectiveness and safety of long-acting granulocyte colony-stimulating factors for prophylaxis of chemotherapy-induced neutropenia in patients with cancer: a systematic review
    Pfeil, Alena M.
    Allcott, Kim
    Pettengell, Ruth
    von Minckwitz, Gunter
    Schwenkglenks, Matthias
    Szabo, Zsolt
    SUPPORTIVE CARE IN CANCER, 2015, 23 (02) : 525 - 545
  • [6] Impact of primary prophylaxis with granulocyte colony-stimulating factor on febrile neutropenia and mortality in adult cancer patients receiving chemotherapy: A systematic review
    Kuderer, Nicole M.
    Dale, David C.
    Crawford, Jeffrey
    Lyman, Gary H.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (21) : 3158 - 3167
  • [7] Clinical practice in febrile neutropenia risk assessment and granulocyte colony-stimulating factor primary prophylaxis of febrile neutropenia in Poland
    Wojtukiewicz, Marek
    Chmielowska, Ewa
    Filipczyk-Cisarz, Emilia
    Krzemieniecki, Krzysztof
    Lesniewski-Kmak, Krzysztof
    Litwiniuk, Maria M.
    Wieruszewska-Kowalczyk, Karolina
    Kosno-Kruszewska, Elzbieta
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2014, 18 (06): : 419 - 424
  • [8] Prophylaxis of chemotherapy-induced febrile neutropenia with granulocyte colony-stimulating factors: where are we now?
    Aapro, Matti
    Crawford, Jeffrey
    Kamioner, Didier
    SUPPORTIVE CARE IN CANCER, 2010, 18 (05) : 529 - 541
  • [9] Prophylaxis of chemotherapy-induced febrile neutropenia with granulocyte colony-stimulating factors: where are we now?
    Matti Aapro
    Jeffrey Crawford
    Didier Kamioner
    Supportive Care in Cancer, 2010, 18 : 529 - 541
  • [10] Risk of chemotherapy-induced febrile neutropenia in patients with metastatic cancer not receiving granulocyte colony-stimulating factor prophylaxis in US clinical practice
    Ahuva Averin
    Amanda Silvia
    Lois Lamerato
    Kathryn Richert-Boe
    Manpreet Kaur
    Devi Sundaresan
    Neel Shah
    Mark Hatfield
    Tatiana Lawrence
    Gary H. Lyman
    Derek Weycker
    Supportive Care in Cancer, 2021, 29 : 2179 - 2186
12345